Completed OBSERVATIONAL NCT05100407

Factors Impacting the Prevalence of MDR Bacteria

Evaluation of the Prevalence and Antibiotic Susceptibility Pattern of Multidrug Resistance Bacteria and Its Association With Patients' Predictive Factors

Sponsor: Kufa University

Conditions Multi-antibiotic Resistance

Updated 5 times since 2021 Last updated: Aug 17, 2022 Started: Mar 1, 2022 Primary completion: May 1, 2022 Completion: May 15, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05100407, this observational or N/A phase trial focuses on Multi-antibiotic Resistance and remains completed. Sponsored by Kufa University, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Apr 2022 — Sep 2022 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Nov 2021 — Apr 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kufa University

Data source: Kufa University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Najaf, Iraq